Search

Your search keyword '"Bydder, Sean A."' showing total 168 results
Start Over Author "Bydder, Sean A."
168 results on '"Bydder, Sean A."'

1. Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial

Author

Abdi, Ehtesham, Allan, Suzanne, Bastick, Patricia, Begbie, Stephen, Blum, Robert, Briscoe, Karen, Brungs, Daniel, Bydder, Sean, Chittajallu, Bala Renuka, Cronk, Michelle, Cuff, Katharine, Davis, Ian D, Dowling, Anthony, Frydenberg, Mark, George, Matthew, Horvath, Lisa, Hovey, Elizabeth, Joshua, Anthony, Karanth, Narayan, Kichenadasse, Ganessan, Krieger, Laurence, Marx, Gavin, Mathlum, Maitham, Nott, Louise, Otty, Zulfiquer, Parnis, Francis, Pook, David, Sandhu, Shahneen, Sewak, Sanjeev, Stevanovic, Amanda, Stockler, Martin, Suder, Aneta, Tan, Hsiang, Torres, Javier, Troon, Simon, Underhill, Craig, Weickhardt, Andrew, Zielinski, Robert, Abbas, Tahir, Anan, Ghadeer, Booth, Chris, Campbell, Holly, Chi, Kim, Chin, Joseph, Chouinard, Edmond, Donnelly, Bryan, Drachenberg, Darrel, Faghih, Amir, Finelli, Antonio, Hotte, Sebastien, Noonan, Krista, North, Scott, Rassouli, Mohammad, Reaume, Neil, Rendon, Ricardo, Saad, Fred, Sadikov, Evgeny, Vigneault, Eric, Zalewski, Pawel, McCaffrey, John, McDermott, Ray, Morris, Patrick, O'Connor, Miriam, Donnellan, Paul, O'Donnell, Dearbhaile, Edwards, Jim, Fong, Peter, Tan, Alvin, Chowdhury, Simon, Crabb, Simon, Khan, Omar, Khoo, Vincent, Macdonald, Graham, Payne, Heather, Robinson, Angus, Shamash, Jonathon, Staffurth, John, Thomas, Carys, Thomson, Alastair, Sweeney, Christopher J, Martin, Andrew J, Stockler, Martin R, Cheung, Leanna, Chi, Kim N, Horvath, Lisa G, Joshua, Anthony M, Lawrence, Nicola J, McJannett, Margaret, North, Scott A, Parulekar, Wendy, Pook, David W, Reaume, Martin Neil, Sandhu, Shahneen K, Tan, Thean Hsiang, Vera-Badillo, Francisco, Williams, Scott G, Winter, Diana, Yip, Sonia, Zhang, Alison Y, and Zielinski, Robert R

Published
2023
Full Text
View/download PDF

4. International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV study

Author

Halkett, Georgia K. B., Wigley, Charles Adam, Aoun, Samar M, Portaluri, Maurizio, Tramacere, Francesco, Livi, Lorenzo, Detti, Beatrice, Arcangeli, Stefano, Lund, Jo-Asmund, Kristensen, Are, McFadden, Nathalie, Grun, Arne, Bydder, Sean, Sackerer, Irina, Greimel, Elfriede, Spry, Nigel, and on behalf of the EORTC Quality of Life Group

Published
2018
Full Text
View/download PDF

8. New Edicts For Letters

Author

Altman, Douglas G., Bydder, Sean, Bamji, Andrew N., Lee, W. R., and Richardson, Robert

Published
2003

9. Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT

Author

de Chavez, Romena, primary, Grogan, Garry, additional, Hug, Ben, additional, Howe, Kate, additional, Grigg, Alice, additional, Waterhouse, David, additional, Lane, Jonathan, additional, Glyde, Alan, additional, Brown, Elizabeth, additional, Bydder, Sean, additional, Pryor, David, additional, Hargrave, Cathy, additional, Charles, Paul H., additional, Hellyer, James, additional, and Ebert, Martin A., additional

Published
2021
Full Text
View/download PDF

10. Giving Medicine A Fair Trial

Author

Allan, Laurie, Tooke, Lance, Rao, Jammi N., Bruzzi, Paolo, Costantini, Massimo, Szebik, Imre, Bydder, Sean, Slevin, Terry, and Katris, Paul

Published
2000

30. Additional file 2: of International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV study

Author

Halkett, Georgia, Wigley, Charles, Aoun, Samar, Portaluri, Maurizio, Tramacere, Francesco, Livi, Lorenzo, Detti, Beatrice, Arcangeli, Stefano, Jo-Asmund Lund, Kristensen, Are, McFadden, Nathalie, Grun, Arne, Bydder, Sean, Sackerer, Irina, Greimel, Elfriede, and Spry, Nigel

Subjects
mental disorders
Abstract

Number of patients with existing co-morbidities and type. (DOCX 13 kb)

Published
2018
Full Text
View/download PDF

31. Additional file 1: of International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV study

Author

Halkett, Georgia, Wigley, Charles, Aoun, Samar, Portaluri, Maurizio, Tramacere, Francesco, Livi, Lorenzo, Detti, Beatrice, Arcangeli, Stefano, Jo-Asmund Lund, Kristensen, Are, McFadden, Nathalie, Grun, Arne, Bydder, Sean, Sackerer, Irina, Greimel, Elfriede, and Spry, Nigel

Abstract

Treatment received by participants. (DOCX 18 kb)

Published
2018
Full Text
View/download PDF

32. Multi‐observer contouring of male pelvic anatomy: Highly variable agreement across conventional and emerging structures of interest

Author

Roach, Dale, primary, Holloway, Lois C, additional, Jameson, Michael G, additional, Dowling, Jason A, additional, Kennedy, Angel, additional, Greer, Peter B, additional, Krawiec, Michele, additional, Rai, Robba, additional, Denham, Jim, additional, De Leon, Jeremiah, additional, Lim, Karen, additional, Berry, Megan E, additional, White, Rohen T, additional, Bydder, Sean A, additional, Tan, Hendrick T, additional, Croker, Jeremy D, additional, McGrath, Alycea, additional, Matthews, John, additional, Smeenk, Robert J, additional, and Ebert, Martin A, additional

Published
2019
Full Text
View/download PDF

38. Invasive brain tumour after radiosurgery

Author

Black, Keith L, Yu, John S, and Bydder, Sean

Subjects
Radiotherapy -- Adverse and side effects, Glioblastoma multiforme -- Risk factors, Brain tumors -- Risk factors
Published
2001

39. Acute radiation proctitis

Author

Leighton, Christopher, Fisher, Barbara, Perera, Francisco, Bydder, Sean, Vernia, Piero, and Casale, Vincenzo

Subjects
Proctitis -- Causes of, Radiation -- Physiological aspects
Published
2001

40. Breast cancer survival advantage with radiotherapy

Author

Atkins, Carl D, Overgaard, Jens, Bartelink, Harry, Ragaz, J, Spinelli, J J, Coldman, A J, Bydder, Sean, Spry, Nigel, Joseph, David J, and Elsaleh, Hany

Subjects
Breast cancer -- Radiotherapy
Published
2000

43. A randomised comparison of three different immobilisation devices for thoracic and abdominal cancers.

Author

Hubie, Catherine, Shaw, Maddison, Bydder, Sean, Lane, Jonny, Waters, Gemma, McNabb, Megan, Kearvell, Rachel, Concannon, Alicia, Bharat, Chrianna, and Appleyard, Rob

Subjects
THERAPEUTIC immobilization, ABDOMINAL cancer, HEALTH of patients, RADIOTHERAPY, PATIENT satisfaction
Abstract

Introduction Patient immobilisation is critically important for both highly conformal conventionally fractionated radiotherapy and for stereotactic body radiotherapy. Different immobilisation devices are available to maintain patient position for radiotherapy but the most suitable one remains unknown. Methods Forty-five patients were randomly allocated to one of three immobilisation devices; the Q fix arm shuttle, Body FIX without wrap or Body FIX with wrap. Patients were imaged before and after treatment to ascertain intra-fraction and inter-fraction motion. Bony anatomy was used for matching to determine the positional accuracy of each device. Treatments were timed using a standard method. Patient comfort and staff satisfaction questionnaires were also issued to determine comfort, ease of use and preferences for each device. Results The Body FIX without wrap was the more accurate device; however, the differences between the devices were not statistically significant. The Body FIX with wrap was found to take significantly longer to set up and set down compared to the arm shuttle and the Body FIX without wrap (all P < 0.001). Patients (37%) marginally preferred the Body FIX with wrap. Most (81%) staff preferred the Body FIX without wrap. Conclusion Immobilisation using the Body FIX without wrap was deemed to be suitable for clinical use. It was a clinically accurate device, the more efficient in terms of set up and set down time, the most preferred by staff and was accepted by patients. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

46. Radiotherapy of abdomen with precise renal assessment with SPECT/CT imaging (RAPRASI): design and methodology of a prospective trial to improve the understanding of kidney radiation dose response

Author

Lopez-Gaitan, Juanita, primary, Ebert, Martin A, additional, Robins, Peter, additional, Boucek, Jan, additional, Leong, Trevor, additional, Willis, David, additional, Bydder, Sean, additional, Podias, Peter, additional, Waters, Gemma, additional, O’Mara, Brenton, additional, Chu, Julie, additional, Faggian, Jessica, additional, Williams, Luke, additional, Hofman, Michael S, additional, and Spry, Nigel A, additional

Published
2013
Full Text
View/download PDF

49. First Australian experience of treating localised prostate cancer patients with CyberKnife stereotactic radiotherapy: early PSAresponse, acute toxicity and quality of life

Author

Dixit, Ashutosh, Tang, Colin, Bydder, Sean, Kedda, Mary-Anne, Vosikova, Eva, Bharat, Chrianna, and Gill, Suki

Abstract

This study is to evaluate biochemical response, acute toxicity and health-related quality-of-life (QOL) outcomes among prostate cancer patients following stereotactic body radiation therapy (SBRT) in the first Australian CyberKnife facility. Forty-five consecutive patients with clinically localised prostate cancer were treated with SBRTusing CyberKnife technology and enrolled in this study. Protocol treatment consisted of 36.25 Gy in five fractions. PSAand acute toxicity was assessed at each follow-up visit and QOLwas assessed using the European Organisation for Research and Treatment of Cancer (EORTC) Global Health Status (GHS) C30 and PR25 questionnaires and the Karnofsky Performance Status (KPS). Distance of travel for treatment was recorded. The median prostate-specific antigen (PSA) level declined from the initial value of 6.9 ng/mL to 1.5 ng/mL at 6 months and 0.6 ng/mL at 18 months post-treatment. Results were similar in patients who did not receive hormone therapy. Acute grade 1 gastrointestinal (GI) and genitourinary (GU) toxicities were found in 11.1% and 24.4% of patients respectively. Acute grade 2 GIand GUtoxicities were found in 2.2% and 11.1% of patients respectively. There were no grade 3 and grade 4 toxicities. Mean urinary symptom score was 14.8 at baseline, 17.2 at 6 weeks and 18.3 at 6 months (P> 0.05). Mean bowel symptom score was 2.7 at baseline, 4.2 at 6 weeks and 6.3 at 6 months (P> 0.05). The mean GHSscore improved from 81.3 at baseline to 82.4 at 6 weeks, and was 75.6 at 6 months (P> 0.05, not significant). Compared to baseline KPS, there was a significant mean decrease from baseline of 96.7 to 93.3 at the 6-week follow-up (P= 0.0043), which then recovered to 94.3 at the 6-month follow-up (P= 0.1387). Early results show promising PSAresponse. Acute toxicity seemed comparable to results from conventionally fractionated radiotherapy and to international prostate SBRTstudies. EORTC PR25 and C30 scores did not reveal any significant change from baseline, and although there was a decrease in KPS, the absolute decrease was small. This study shows the early results of curative intent stereotactic body radiation therapy using CyberKnife technology for clinically localised prostate cancer for the first time in Australia.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results